Heat-Shock Protein 27 kinetics in end stage renal disease patients
<p>Atherosclerosis is one of the most significant yet unresolved problems in patients on regular Hemodialysis (HD) with major impact on morbidity and mortality of patients with end-stage renal disease (ESRD). There is growing evidence that atherosclerosis may-at least in part- result from auto...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Archives of Clinical Nephrology - Peertechz Publications,
2020-09-16.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | <p>Atherosclerosis is one of the most significant yet unresolved problems in patients on regular Hemodialysis (HD) with major impact on morbidity and mortality of patients with end-stage renal disease (ESRD). There is growing evidence that atherosclerosis may-at least in part- result from autoimmune processes, in which the family of Heat-Shock Proteins (HSP) may be involved [1].</p> |
|---|---|
| DOI: | 10.17352/acn.000043 |